Leadership Team

Matthew Wiener PharmD
CEO
Dr. Matthew Wiener has over 35 years of experience as a clinical research pharmacist. He has been a faculty member at Columbia College of Pharmaceutical Sciences, the University of Colorado, and National Jewish Health; additionally, he directed a private practice research center. Dr. Wiener began his career in oncology, which led him to found Pharmatech, a CRO focused on oncology trials. Under his leadership, Pharmatech pioneered the concept of Just-In-Time clinical trials, significantly reducing the time to start trials and becoming a leader in the field. In 2019, Pharmatech was acquired by Caris Lifesciences, and in 2021, Dr. Wiener founded Clinika Research. He is well-published and a noted speaker on clinical product development and managed care research. Dr. Wiener holds a Doctorate in Pharmacy from Columbia College and a BS in Pharmacy from Brooklyn College of Pharmacy.

Joanna Zeiger MS, PhD
CSO

Hali Broncucia MAEd
COO

Dr. Joanna Zeiger is a renowned cannabis epidemiologist and the Founder and CEO of Canna Research Foundation, a non-profit that focuses on the epidemiological aspects of medical cannabis use. She is the epidemiologist and biostatistician for Clinika Research. Dr. Zeiger has published prolifically in peer-reviewed journals and speaks at conferences and community events. She serves on the Governing Board for the Institute of Cannabis Research at CSU Pueblo. From 1998 to 2010, Dr. Zeiger was a professional athlete, competing in triathlons at an international level, including a 4th place finish at the 2000 Sydney Olympics and a world record win at the 2008 Ironman 70.3 World Championships. Her book, The Champion Mindset: An Athlete’s Guide to Mental Toughness, was published in 2017. Dr. Zeiger holds a BA from Brown University, an MS from Northwestern University, and a PhD from the Johns Hopkins Bloomberg School of Public Health.
Hali Broncucia, MAEd, has devoted over 15 years to research in endocrinology and Type 1 Diabetes, primarily through observational and clinical trials. She has managed more than 10 clinical trials as the research manager at the Barbara Davis Center for Diabetes, focusing on interventions to delay or prevent Type 1 Diabetes. In 2022, Ms. Broncucia joined Clinika Research as the Chief Operations Officer, aiming to enhance support to sponsors, CROs, and clinical sites with her expertise. She earned her BA in Integrative Physiology from the University of Colorado and a Master of Arts in Secondary Science Education from the University of Phoenix.